Search Results
Results found for "Neurocrine Biosciences"
Posts (39)
- Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special.
- Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special.
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
announces that in connection with the Collaboration and License Agreement (“License Agreement”) with Neurocrine Biosciences, Inc. (“Neurocrine Biosciences”) announced 22 November 2021, the applicable waiting period under the Hart-Scott-Rodino completion of the applicable waiting period under the HSR Act, under the terms of the License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares an upfront payment of US$100 million, with the amount to
Other Pages (9)
- Scott Struthers | Dr. GPCR Ecosystem
Prior to Crinetics, he was senior director and head of endocrinology and metabolism at Neurocrine Biosciences At Neurocrine, he initiated and led the effort to discover and develop orally active, nonpeptide GnRH Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
When Sam Hoare and the CRF receptor team at Neurocrin Biosciences discovered that their lead compound Biosciences working on CRF receptor drug discovery programs that advanced compounds into clinical trials The Neurocrin team had to confront an explanation no assay had been designed to find — and then built Biosciences 43:25 The off-rate aha moment: seven hours on the receptor versus fifteen minutes 52:22 Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Scientific Officer and VP of Protein Engineering at Twist Biopharma, the biologics division of Twist Bioscience 01:53 The conversation begins 02:29 From MIT crystallography to leading Twist Biopharma 04:21 Twist Bioscience Aaron Sato from Twist Biopharma , a vertical within Twist Bioscience . During our time together, Aaron and I discussed how using Twist Bioscience’s proprietary technology to Aaron Sato on the web LinkedIn Twitter Google Scholar Twist Bioscience Twist Biopharma Dr.
